Mild cognitive impairment (MCI) is a transitional state of cognitive decline that is below the average age-related fall off in mental skills but above the threshold for dementia. It is also called ...

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably higher likelihood of developing non-amnestic mild cognitive impairment.

Cognitive impairment frequently coexists with heart failure, and the condition can negatively impact patients’ prognosis and hinder their independence and ability to fully participate in their care. A ...

EHR-driven identification and outreach target older adults at high risk for cognitive impairment, addressing evidence that most mild cognitive impairment remains undetected in primary care. Community ...

Diabetes mellitus, encompassing both type 1 and type 2 diabetes, is increasingly recognised not only for its metabolic disturbances but also for its impact on cognitive health. A growing body of ...

There's been a flurry of attention around a new study in Frontiers in Neurology validating that the Brain Care Score, or BCS, may help in assessing one's risk of developing dementia or having a stroke ...

Exercise may reduce cancer-related cognitive impairment among people starting chemotherapy, according to results of a ...

When someone experiences early-stage memory loss or other cognitive problems, it often leads to a diagnosis of mild cognitive impairment (MCI). In mild cognitive impairment, changes in memory or ...